Pfizer Inc. (PFE) Fundamentals

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
SHARE INFORMATION
Market Cap$ 279,831,861,197
Shares Outstanding5,612,351,809
Float5,611,282,467
Percent Float99.98%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 1.56
Latest Fiscal Revenue$ 81,288,000,000
Latest Fiscal EPS$ 3.84
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 3.87
Dividend (5 Years)$ 5.00
Ex Dividend Date2022-07-28
Dividend Rate$ 1.60
Dividend Yield3.21%
Payment CashCash
HOLDERS
Institutions4,901
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months385,680,626
Institutional Holdings Percent132.9%
Institutional Sold Previous 3 Months286,290,188
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months231,227
Insider Holdings Percent0.3
Insider Sold Previous 3 Months149,709
Insider Shares Owned15,202,250
TRADING INFO
52 Week High$ 61.71
52 Week Low$ 40.94
52 Week High Change$ 5.27
21 Day Moving Average$ 50.2673
21 Day Extended Moving Average$ 50.2277
50 Day Moving Average$ 50.4736
50 Day Extended Moving Average$ 50.6912
200 Day Moving Average$ 50.8774
200 Day Extended Moving Average$ 49.8618
10 Day Average Volume19,414,852
20 Day Average Volume19,160,043
30 Day Average Volume17,905,086
50 Day Average Volume19,262,665
Alpha0.007011
Beta0.6768
Standard Deviation0.074435
R20.206784
7 Day Price Change$ 0.08
7 Day Percent Change0.16%
21 Day Price Change$ -2.04
21 Day Percent Change-3.93%
30 Day Price Change$ -1.49
30 Day Percent Change-2.9%
Month to Date Price Change$ -0.65
Month to Date Percent Change-1.29%
Quarter to Date Price Change$ -2.17
Quarter to Date Percent Change-4.16%
180 Day Price Change$ 0.9613
180 Day Percent Change1.97%
200 Day Price Change$ -3.62
200 Day Percent Change-6.76%
Year to Date Price Change$ -7.82
Year to Date Percent Change-13.56%

Pfizer Inc. (PFE) Key Ratios

PROFITABILITY
EBIT Margin33.0%
EBITDA Margin38.0%
Pre-Tax Profit Margin9.7%
Profit Margin Count29.6%
Gross Margin62.2%
Profit Margin TOT29.18%
INCOME STATEMENTS
Revenue$ 101,132,000,000
Revenue Per Share$ 18.0195
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book33.80
Total Debt To Equity0.50
Int Coverage26.70
Current Ratio1.40
Leverage Ratio2.30
Quick Ratio1.10
Long Term Debt To Capital0.28
VALUATION MEASURES
PE Ratio9.80
Enterprise Value$ 310,832,944,731
Price to Sales2.767
Price to Free Cash20.90
PE High Last 5 Years36.10
Price To Book3.20
Price To Cash Flow9.10
PE Low Last 5 Years8.90
Price to Tangible Book33.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.10
Invoice Turnover4.00
Assets Turnover0.60
Return Assets16.97
Return on Equity39.31
Return on Capital25.67

Pfizer Inc. (PFE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOAlbert Bourla
Emplyoees79000
Last AuditUE
CIK0000078003
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address235 East 42nd Street
New York, NY 10017
Websitehttps://www.pfizer.com
Facsimile-
Telephone+1 212 733-2323
Email-


Your Recent History
NYSE
PFE
Pfizer
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.